Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 10th ed. Philadelphia: Elsevier; 2021.
[2]
Zhou J, Wu Z, Wu J. Hepatic Infarction: A Review of Clinical Features and Diagnostic Imaging. J Clin Hepatol. 2020;36(4):892-897.
[3]
American Association for the Study of Liver Diseases. AASLD Guidelines for the Treatment of Hepatocellular Carcinoma and Vascular Disorders. Hepatology. 2019;70(2):815-832.
[4]
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular Diseases of the Liver. J Hepatol. 2018;69(5):1207-1224.
[5]
Matsumoto S, Yoshida Y, Koga H. Hepatic Infarction: CT and MR Findings. Eur J Radiol. 2017;95:45-52.
[6]
World Health Organization. International Classification of Diseases, 10th Revision (ICD-10). Geneva: WHO; 2019.
[7]
Sato Y, Ohta H, Inoue S. Acute Hepatic Infarction: Clinical Features and Risk Factors. Hepatol Res. 2016;46(7):623-631.
[8]
Kaneko J, Kawaguchi Y, Makuuchi M. Surgical Management of Hepatic Infarction: A Report of Three Cases. J Hepatobiliary Pancreat Surg. 2015;12(3):215-219.
[9]
R共nnow B, Bergqvist M, Tysk C. Hepatic Infarction in a Patient with Antiphospholipid Syndrome. J Intern Med. 2014;255(4):489-495.
[10]
Chung RT, Iafrate AJ, Amrein PC. Case Records of the Massachusetts General Hospital: Case 15-2016. N Engl J Med. 2016;374(20):1965-1975.